S100 calcium-binding protein A9 promotes skin regeneration through toll-like receptor 4 during tissue expansion

Abstract

Background: In plastic surgery, tissue expansion is widely used for repairing skin defects. However, low expansion efficiency and skin rupture caused by thin, expanded skin remain significant challenges in promoting skin regeneration during expansion. S100 calcium-binding protein A9 (S100A9) is essential in promoting wound healing; however, its effects on skin regeneration during tissue expansion remain unclear. The aim of the present study was to explore the role of S100A9 in skin regeneration, particularly collagen production to investigate its importance in skin regeneration during tissue expansion. Methods: The expression and distribution of S100A9 and its receptors-toll-like receptor 4 (TLR-4) and receptor for advanced glycation end products were studied in expanded skin. These characteristics were investigated in skin samples of rats and patients. Moreover, the expression of S100A9 was investigated in stretched keratinocytes in vitro. The effects of S100A9 on the proliferation and migration of skin fibroblasts were also observed. TAK-242 was used to inhibit the binding of S100A9 to TLR-4; the levels of collagen I (COL I), transforming growth factor beta (TGF-β), TLR-4 and phospho-extracellular signal-related kinase 1/2 (p-ERK1/2) in fibroblasts were determined. Furthermore, fibroblasts were co-cultured with stretched S100A9-knockout keratinocytes by siRNA transfection and the levels of COL I, TGF-β, TLR-4 and p-ERK1/2 in fibroblasts were investigated. Additionally, the area of expanded skin, thickness of the dermis, and synthesis of COL I, TGF-β, TLR-4 and p-ERK1/2 were analysed to determine the effects of S100A9 on expanded skin. Results: Increased expression of S100A9 and TLR-4 was associated with decreased extracellular matrix (ECM) in the expanded dermis. Furthermore, S100A9 facilitated the proliferation and migration of human skin fibroblasts as well as the expression of COL I and TGF-β in fibroblasts via the TLR-4/ERK1/2 pathway. We found that mechanical stretch-induced S100A9 expression and secretion of keratinocytes stimulated COL I, TGF-β, TLR-4 and p-ERK1/2 expression in skin fibroblasts. Recombined S100A9 protein aided expanded skin regeneration and rescued dermal thinning in rats in vivo as well as increasing ECM deposition during expansion. Conclusions: These findings demonstrate that mechanical stretch promoted expanded skin regeneration by upregulating S100A9 expression. Our study laid the foundation for clinically improving tissue expansion using S100A9.

Keywords

S100 calcium-binding protein A9 / Skin / Soft tissue expansion / Mechanical stretch / Regeneration

References

[1] Azadgoli B, Fahradyan A, Wolfswinkel EM, Tsuha M, Magee W, 3rd, Hammoudeh JA, et al. External port tissue expansion in the pediatric population: confirming its safety and efficacy. Plast Reconstr Surg. 2018; 141: 883e-90.

[2] Neumann CG.The expansion of an area of skin by progressive distention of a subcutaneous balloon; use of the method for securing skin for subtotal reconstruction of the ear. Plast Reconstr Surg. 1957; 19: 124-30.

[3] Huang Z, Ding J, Song Y, Liu W, Dong C, Zhang Y, et al. Macrophage contribution to the survival of transferred expanded skin flap through angiogenesis. Ann Transl Med. 2023; 11: 248.

[4] Patel PA, Elhadi HM, Kitzmiller WJ, Billmire DA, Yakuboff KP. Tissue expander complications in the pediatric burn patient: a 10-year follow-up. Ann Plast Surg. 2014; 72: 150-4.

[5] van Rappard JH, Sonneveld GJ, Borghouts JM. Histologic changes in soft tissues due to tissue expansion (in animal studies and humans). Facial Plast Surg. 1988; 5: 280-6.

[6] Zhang Y, Yu Z, Lei L, Song Y, Liu S, Cui J, et al. Secreted PEDF modulates fibroblast collagen synthesis through M1 macrophage polarization under expanded condition. Biomed Pharmacother. 2021; 142: 111951.

[7] Tan PC, Zhou SB, Ou MY, He JZ, Zhang PQ, Zhang XJ, et al. Mechanical stretching can modify the papillary dermis pattern and papillary fibroblast characteristics during skin regeneration. J Invest Dermatol. 2022; 142: 2384-94.

[8] Purnell CA, Gart MS, Buganza-Tepole A, Tomaszewski JP, Topczewska JM, Kuhl E, et al. Determining the differential effects of stretch and growth in tissue-expanded skin: combining isogeometric analysis and continuum mechanics in a porcine model. Dermatol Surg. 2018; 44: 48-52.

[9] Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in inflammation. Front Immunol. 2018; 9: 1298.

[10] Kotsiou OS, Papagiannis D, Papadopoulou R, Gourgoulianis KI. Calprotectin in lung diseases. Int J Mol Sci. 2021; 22: 1706.

[11] Willers M, Ulas T, Völlger L, Vogl T, Heinemann AS, Pirr S, et al. S100A8 and S100A9 are important for postnatal development of gut microbiota and immune system in mice and infants. Gastroenterology. 2020; 159: 2130-45.

[12] Gao RY, Jia HM, Han YZ, Qian BS, You P, Zhang XK, et al. Calprotectin as a diagnostic marker for sepsis: a meta-analysis. Front Cell Infect Microbiol. 2022; 12: 1045636.

[13] Dessing MC, Tammaro A, Pulskens WP, Teske GJ, Butter LM, Claessen N, et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 2015; 87: 85-94.

[14] Gasparitsch M, Arndt AK, Pawlitschek F, Oberle S, Keller U, Kasper M, et al. RAGE-mediated interstitial fibrosis in neonatal obstructive nephropathy is independent of NF-κB activation. Kidney Int. 2013; 84: 911-9.

[15] Yiu WH, Lok SWY, Xue R, Chen J, Lai KN, Lan HY, et al. The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy. Clin Sci (Lond). 2023; 137: 317-31.

[16] Araki K, Kinoshita R, Tomonobu N, Gohara Y, Tomida S, Takahashi Y, et al. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis. J Mol Med (Berl). 2021; 99: 131-45.

[17] Basu A, Munir S, Mulaw MA, Singh K, Crisan D, Sindrilaru A, et al. A novel S100A8/A9 induced fingerprint of mesenchymal stem cells associated with enhanced wound healing. Sci Rep. 2018; 8: 6205.

[18] Zhong A, Xu W, Zhao J, Xie P, Jia S, Sun J, et al. S100A8 and S100A9 are induced by decreased hydration in the epidermis and promote fibroblast activation and fibrosis in the dermis. Am J Pathol. 2016; 186: 109-22.

[19] Liu W, Xiong S, Zhang Y, Du J, Dong C, Yu Z, et al. Transcriptome profiling reveals important transcription factors and biological processes in skin regeneration mediated by mechanical stretch. Front Genet. 2021; 12: 757350.

[20] Aragona M, Sifrim A, Malfait M, Song Y, Van Herck J, Dekoninck S, et al. Mechanisms of stretch-mediated skin expansion at single-cell resolution. Nature. 2020; 584: 268-73.

[21] Xue Y, Lyu C, Taylor A, Van Ee A, Kiemen A, Choi Y, et al. Mechanical tension mobilizes Lgr6(+) epidermal stem cells to drive skin growth. Sci Adv. 2022; 8: l8698.

[22] Cheng X, Yu Z, Song Y, Zhang Y, Du J, Su Y, et al. Hair follicle bulge-derived stem cells promote tissue regeneration during skin expansion. Biomed Pharmacother. 2020; 132: 110805.

[23] Hu H, Feng N, Shen X, Zhao L, Zheng D. Transcriptomic analysis of Vigna radiata in response to chilling stress and uniconazole application. BMC Genomics. 2022; 23: 205.

[24] Fang Y, Wu D, Birukov KG. Mechanosensing and Mechanoregulation of endothelial cell functions. Compr Physiol. 2019; 9: 873-904.

[25] Mazza R, Mazzette R. Absolute and relative gene expression in listeria monocytogenes using real-time PCR. Methods Mol Biol. 2014; 1157: 213-21.

[26] Xu X, Chen Z, Zhu X, Wang D, Liang J, Zhao C, et al. S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1/2 MAPK and NF-κB pathways. Iran J Basic Med Sci. 2018; 21: 194-201.

[27] Xu X, Chen H, Zhu X, Ma Y, Liu Q, Xue Y, et al. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways. Clin Exp Immunol. 2013; 173: 523-35.

[28] Zhang W, Lavine KJ, Epelman S, Evans SA, Weinheimer CJ, Barger PM, et al. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J Am Heart Assoc. 2015; 4: e1993.

[29] Railwah C, Lora A, Zahid K, Goldenberg H, Campos M, Wyman A, et al. Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2020; 319: L1021-35.

[30] Razzak MA, Hossain MS, Radzi ZB, Yahya NA, Czernuszka J, Rahman MT. Cellular and molecular responses to mechanical expansion of tissue. Front Physiol. 2016; 7: 540.

[31] Sprenkeler EGG, Zandstra J, van Kleef ND, Goetschalckx I, Verstegen B, Aarts CEM, et al. S100A8/A9 is a marker for the release of neutrophil extracellular traps and induces neutrophil activation. Cell. 2022; 11: 236.

[32] Polakowska M, Steczkiewicz K, Szczepanowski RH, Wysłouch-Cieszyńska A. Toward an understanding of the conformational plasticity of S100A8 and S100A9 Ca2+-binding proteins. J Biol Chem. 2023; 299: 102952.

[33] Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut. 2021; 70: 1978-88.

[34] Ding J, Lei L, Liu S, Zhang Y, Yu Z, Su Y, et al. Macrophages are necessary for skin regeneration during tissue expansion. J Transl Med. 2019; 17: 36.

[35] Honma M, Nozaki H. Molecular pathogenesis of psoriasis and biomarkers reflecting disease activity. J Clin Med. 2021; 10: 3199.

[36] Wang Q, Chen W, Lin J. The role of calprotectin in rheumatoid arthritis. J Transl Int Med. 2019; 7: 126-31.

[37] Lv Z, Li W, Wei X. S100A9 promotes prostate cancer cell invasion by activating TLR4/NF-κB/integrin β1/FAK signaling. Onco Targets Ther. 2020; 13: 6443-52.

[38] Kim HA, Han JH, Kim WJ, Noh HJ, An JM, Yim H, et al. TLR4 endogenous ligand S100A8/A9 levels in adult-onset Still’s disease and their association with disease activity and clinical manifestations. Int J Mol Sci. 2016; 17: 1342.

[39] Chen X, Tao T, Wang H, Zhao H, Lu L, Wu F. Arterial thrombosis is accompanied by elevated mitogen-activated protein kinase (MAPK) and cyclooxygenase-2 (COX-2) expression via toll-like receptor 4 (TLR-4) activation by S100A8/A9. Med Sci Monit. 2018; 24: 7673-81.

[40] Zhong X, Xie F, Chen L, Liu Z, Wang Q. S100A8 and S100A9 promote endothelial cell activation through the RAGE-mediated mammalian target of rapamycin complex 2 pathway. Mol Med Rep. 2020; 22: 5293-303.

[41] Yin C, Li H, Zhang B, Liu Y, Lu G, Lu S, et al. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition. Breast Cancer Res Treat. 2013; 142: 297-309.

[42] Xie J, Méndez JD, Méndez-Valenzuela V, Aguilar-Hernández MM. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 2013; 25: 2185-97.

[43] Ogawa R, Hsu CK. Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degeneration. J Cell Mol Med. 2013; 17: 817-22.

[44] Mony MP, Harmon KA, Hess R, Dorafshar AH, Shafikhani SH. An updated review of hypertrophic scarring. Cell. 2023; 12: 678.

[45] Xu X, Wu WY, Tu WZ, Chu HY, Zhu XX, Liang MR, et al. Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities. Clin Rheumatol. 2013; 32: 1501-10.

[46] Du Y, Cai Y, Lv Y, Zhang L, Yang H, Liu Q, et al. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma. Cancer Lett. 2022; 551: 215972.

[47] Chen YT, Wang CC, Cheng CP, Liu FC, Lee CH, Lee HS, et al. Interleukin-26 has synergistic catabolic effects with palmitate in human articular chondrocytes via the TLR4-ERK1/2-c-Jun signaling pathway. Cell. 2021; 10: 2500.

[48] Zou X, Zhou Q, Nie Y, Gou J, Yang J, Zhu J, et al. Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway. BMC Cancer. 2022; 22: 595.